| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $143.00M | $142.90M | $110.78M | $91.77M | $78.87M |
| R&D | $109.82M | $114.07M | $85.17M | $61.68M | $56.86M |
| SG&A | $33.19M | $28.82M | $25.61M | $25.09M | $22.01M |
| Operating Income | -$143.00M | -$142.90M | -$110.78M | -$91.77M | -$78.87M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$129.47M | -$127.85M | -$100.70M | -$89.12M | -$78.72M |
| EPS (basic) | -1.4700 | -1.8300 | -1.9600 | -2.2500 | -2.0700 |
| EPS (diluted) | -1.4700 | -1.8300 | -1.9600 | -2.2500 | -2.0700 |
| Shares (diluted) | $87.79M | $69.73M | $51.45M | $39.66M | $37.95M |